S. Korea’s KT&G Launches KT&G Life Sciences To Steer Pharma Business
This article was originally published in PharmAsia News
South Korea’s KT&G, a tobacco and ginseng conglomerate, said it has renamed its Mazence unit to become KT&G Life Sciences to spearhead its expansion in the pharmaceutical business.
You may also be interested in...
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
Early Research Suggests Wearables Can Spot Early Signs Of COVID-19; Fitbit Receives $2.5m Army Award
A consortium of researchers, including Fitbit, are developing algorithms to spot COVID-19 before people become ill.